Akina Harada

TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms

Kazunori Suzuki, Akina Harada, Hirobumi Suzuki et al. · Neuropsychopharmacology · 2016 · 58 citations · Full text

Neuropsychology, Psychoactive Drug, Psychiatry +12

In Vivo Pharmacological Characterization of TAK-063, a Potent and Selective Phosphodiesterase 10A Inhibitor with Antipsychotic-Like Activity in Rodents

Kazunori Suzuki, Akina Harada, Eri Shiraishi et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 50 citations

TAK-063, a Novel Phosphodiesterase 10A Inhibitor, Protects from Striatal Neurodegeneration and Ameliorates Behavioral Deficits in the R6/2 Mouse Model of Huntington’s Disease

Akina Harada, Kazunori Suzuki, Haruhide Kimura · Journal of Pharmacology and Experimental Therapeutics · 2016 · 36 citations

Gene and protein analysis of brain derived neurotrophic factor expression in relation to neurological recovery induced by an enriched environment in a rat stroke model

Kenji Hirata, Yuji Kuge, Chiaki Yokota et al. · Neuroscience Letters · 2011 · 30 citations

Neuroregeneration, Stroke Rehabilitation, Neurophysiology +15

Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A

Akina Harada, Kazunori Suzuki, Shotaro Miura et al. · Nuclear Medicine and Biology · 2014 · 30 citations

Protein Function, Signal Transduction, Biochemistry +9